Live Oak Private Wealth’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.48M | Buy |
11,038
+1,167
| +12% | +$473K | 0.67% | 52 |
|
|
2025
Q1 | $4.91M | Buy |
9,871
+1,176
| +14% | +$585K | 0.8% | 47 |
|
|
2024
Q4 | $4.52M | Buy |
8,695
+1,791
| +26% | +$932K | 0.76% | 51 |
|
|
2024
Q3 | $4.27M | Buy |
6,904
+403
| +6% | +$249K | 0.69% | 52 |
|
|
2024
Q2 | $3.6M | Buy |
6,501
+185
| +3% | +$102K | 0.62% | 57 |
|
|
2024
Q1 | $3.67M | Buy |
6,316
+5,881
| +1,352% | +$3.42M | 0.64% | 53 |
|
|
2023
Q4 | $231K | Hold |
435
| – | – | 0.04% | 148 |
|
|
2023
Q3 | $220K | Hold |
435
| – | – | 0.05% | 143 |
|
|
2023
Q2 | $227K | Hold |
435
| – | – | 0.05% | 147 |
|
|
2023
Q1 | $251K | Sell |
435
-6
| -1% | -$3.46K | 0.05% | 136 |
|
|
2022
Q4 | $243K | Hold |
441
| – | – | 0.05% | 148 |
|
|
2022
Q3 | $224K | Hold |
441
| – | – | 0.05% | 151 |
|
|
2022
Q2 | $240K | Buy |
441
+30
| +7% | +$16.3K | 0.05% | 154 |
|
|
2022
Q1 | $243K | Sell |
411
-4
| -1% | -$2.37K | 0.05% | 156 |
|
|
2021
Q4 | $277K | Buy |
415
+2
| +0.5% | +$1.34K | 0.05% | 156 |
|
|
2021
Q3 | $236K | Buy |
+413
| New | +$236K | 0.05% | 161 |
|